tiprankstipranks
Trending News
More News >
AstraZeneca PLC (AZNCF)
OTHER OTC:AZNCF
Advertisement

AstraZeneca (AZNCF) Stock Statistics & Valuation Metrics

Compare
212 Followers

Total Valuation

AstraZeneca has a market cap or net worth of £215.17B. The enterprise value is $244.54B.
Market Cap£215.17B
Enterprise Value$244.54B

Share Statistics

AstraZeneca has 1,550,670,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,550,670,700
Owned by Insiders0.03%
Owned by Institutions0.01%

Financial Efficiency

AstraZeneca’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 10.30%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)10.30%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee573.41K
Profits Per Employee92.16K
Employee Count94,300
Asset Turnover0.52
Inventory Turnover1.93

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio27.8
PS Ratio0.00
PB Ratio5.31
Price to Fair Value4.98
Price to FCF22.51
Price to Operating Cash Flow16.64
PEG Ratio2.71

Income Statement

In the last 12 months, AstraZeneca had revenue of 54.07B and earned 7.04B in profits. Earnings per share was 4.54.
Revenue54.07B
Gross Profit43.87B
Operating Income10.00B
Pretax Income8.69B
Net Income7.04B
EBITDA15.44B
Earnings Per Share (EPS)4.54

Cash Flow

In the last 12 months, operating cash flow was 13.09B and capital expenditures -3.41B, giving a free cash flow of 9.68B billion.
Operating Cash Flow13.09B
Free Cash Flow9.68B
Free Cash Flow per Share6.24

Dividends & Yields

AstraZeneca pays an annual dividend of $2.128, resulting in a dividend yield of 2.23%
Dividend Per Share$2.128
Dividend Yield2.23%
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.23
52-Week Price Change-10.75%
50-Day Moving Average141.45
200-Day Moving Average140.13
Relative Strength Index (RSI)46.94
Average Volume (3m)2.34K

Important Dates

AstraZeneca upcoming earnings date is Jul 29, 2025, Before Open (Confirmed).
Last Earnings DateApr 29, 2025
Next Earnings DateJul 29, 2025
Ex-Dividend DateFeb 20, 2025

Financial Position

AstraZeneca as a current ratio of 0.93, with Debt / Equity ratio of 77.29%
Current Ratio0.93
Quick Ratio0.74
Debt to Market Cap0.14
Net Debt to EBITDA1.60
Interest Coverage Ratio5.95

Taxes

In the past 12 months, AstraZeneca has paid 1.65B in taxes.
Income Tax1.65B
Effective Tax Rate0.19

Enterprise Valuation

AstraZeneca EV to EBITDA ratio is 14.74, with an EV/FCF ratio of 31.29.
EV to Sales4.21
EV to EBITDA14.74
EV to Free Cash Flow31.29
EV to Operating Cash Flow19.19

Balance Sheet

AstraZeneca has £5.39B in cash and marketable securities with $31.72B in debt, giving a net cash position of £26.32B billion.
Cash & Marketable Securities£5.39B
Total Debt$31.72B
Net Cash£26.32B
Net Cash Per Share£16.97
Tangible Book Value Per Share-£11.18

Margins

Gross margin is 81.41%, with operating margin of 18.50%, and net profit margin of 13.01%.
Gross Margin81.41%
Operating Margin18.50%
Pretax Margin16.07%
Net Profit Margin13.01%
EBITDA Margin28.55%
EBIT Margin19.29%

Analyst Forecast

The average price target for AstraZeneca is £180.86, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target£180.86
Price Target Upside29.46% Upside
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score8
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis